Member Info for ROCKZ

Busy, news is due, the company could enter Phase 2 Covid trials any day.

This could bounce hard. The drop in the last month has been over done. Only 1% less than PRVB which has had some negative news recently ref. FDA approval but continues to recover.

Cheers Paul, is there a telegram group set up for TILS aswell?

Mr Wong, I think you’re wrong. I can’t see LTH dumping at these levels to buy into Accustem.
Many will have overloaded on TILS at these levels and may de-risk at the next inevitable rise.
If the price is right at the time for both of these stocks some of this money might find it’s way into Accustem.

Jack, ShirazKhan was the guys name. Yes, he seemed to build up a meaty holding and posts very occasionally now.
Remember Manabouttown aswell? There was one that posted frantically about how good this stock was and then suddenly disappeared in a puff of smoke!

I am staying positive, really like the company but what a mess this demerger has been.
GC mentioned previously that it may be an option to demerge more of TILS drug pipeline in order to extract maximum value for shareholders.
Let’s hope he’s learnt some lessons from this debacle.

That’s why they refer to Shailubhai as the GOAT over on Stockwits lol

Paul, let’s hope LSE set up an Accustem page sooner rather than later. Some of the discussion is needed on this board though as some of us are still in the dark with our brokers.

PRVB down 30% today and both TILS/TLSA holding pretty solid.

I try and take the positives out of this.
I would suspect one of the big pharma companies had PRVB lined up for a takeover purely on the FDA approval of Teplizumab.
Maybe those big pharma will turn their attention to TILS now.

Sang, yes he did say it would be great to have another company chopping down trees ahead of you.
He was solely relating to the IV route for Foralumab which the company are not developing at present.

PRVB down 24% pre market. Not sure it will effect TILS too much, IV wasn’t on the table at this point.
It might even open a door for TILS to move in to diabetes as the only anti CD3, Fully human monoclonal antibody with a smaller more suitable dose with less toxicity.

It is a joke. I’m not blaming the company for the record, I think they’ve been badly advised on the demerger process.
I have set the wheels in process for a transfer Barclays to Lloyds but I am pretty chilled as I reckon there will be a massive overhang of shares for the first week or two.
Probably totally wrong though as these things don’t always play out as we expect price action wise, eg StemprintER back in October!

Lol it’s chaos, even the brokers don’t seem to know.
Doesn’t help that their working from home.

Same here, I’m still in the dark. I’ve been badgering Barclays most days and hopefully I’ll hear something this week.

Extremely low volume today. Not many buying, not many selling.

‘The Company also confirms that it has re-activated its strategic plan to redomicile to Bermuda; shareholders will receive further information in due course’.
Interesting..Nasdaq sole listing in the future??

Hi Greend, you’re in a good position then with HL as your broker as they trade US shares. You will automatically get the Accustem shares which should be showing in your portfolio already with no value attributed. You just need to fill in the W-8BEN form if you haven’t done so already.

Greend, it depends on your broker. Who is your broker?

Crazy to sell at these levels with the positive news flow and the US pre market looking buoyant.